Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Fewer people are dying from systemic sclerosis at younger ages

Key clinical point: Mortality of people with systemic sclerosis (SSc) aged 44 and younger now rivals the death rate for the general population in that age group.

Major finding: The ratio of SSc to non-SSc ASMRs between 1968 and 2015 in the group aged 44 and younger declined 20.0%, whereas there was a 53.1% cumulative increase in the 45- to 64-year-old group and a 395.4% cumulative increase in the 65-year-old and older group.

Study details: An analysis of 46,798 adults who died from SSc-related causes between 1968 and 2015 compared with adults who died in the general population over the same time period.

Disclosures: The presenter reported no conflicts of interest.

Citation:

Yen E et al. Arthritis Rheumatol. 2019;71(suppl 10), Abstract 825.